news Cilcare launches a groundbreaking 3D Bioprinting Project with human cells to advance therapies for hearing disorders Learn More > 23 6月 2025 Cilcare and CBSET publish White Paper on gene therapy for hearing loss in World Pharma Today Learn More > 20 5月 2025 Cilcare launches a new study to explore hearing in patients with early-stage neurodegenerative diseases and identify new auditory biomarkers Learn More > 10 2月 2025 Cilcare to exhibit at ARO 2025 and present at the PIHL Satellite Symposium Learn More > 4 2月 2025 Cilcare appoints Dr. Preethi Sundaram to its Board of Directors Learn More > 30 1月 2025 Cilcare appoints Dr. Bettina M. Cockroft as Chief Medical Officer Learn More > 17 1月 2025 Cilcare completes a €40M series A Learn More > 4 12月 2024 10 years of innovation for Making Hearing A Priority Learn More > 2 12月 2024 Cilcare appoints Mélanie Berta as Project Manager, Drug Development Learn More > 7 11月 2024 « Previous ページ1 ページ2 ページ3 ページ4 ページ5 … ページ28 Next »
Cilcare launches a groundbreaking 3D Bioprinting Project with human cells to advance therapies for hearing disorders Learn More > 23 6月 2025
Cilcare and CBSET publish White Paper on gene therapy for hearing loss in World Pharma Today Learn More > 20 5月 2025
Cilcare launches a new study to explore hearing in patients with early-stage neurodegenerative diseases and identify new auditory biomarkers Learn More > 10 2月 2025
